Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Communique from the Annual General Meeting in 2cureX AB (publ)

Today, on May 28th, 2019, the Annual General Meeting (“AGM”) was held in 2cureX AB (publ). Below follows a summary of the resolutions. The resolutions were passed with the required majority.Disposition of the company’s profit or loss The AGM resolved to dispose of the company's results according to the Board's proposal in the annual report. The AGM also resolved that no dividend be paid for the financial year 2018. In addition, the AGM resolved to grant discharge from liability to the members of the Board and the CEO for the financial year 2018. Determination of the number of Board

Dig into Stellaris: Ancient Relics Starting June 4

Study Up with a Feature Breakdown Trailer for the Story Pack; Pre-Orders Available NowSTOCKHOLM - May 28, 2019 - Paradox Interactive, a publisher and developer of games you can really dig into, today announced that Stellaris’ upcoming story pack, Ancient Relics, will launch June 4th, 2019 on Windows, Mac, and Linux for the suggested retail price of $9.99 USD. Ancient Relics will add two new Precursors to investigate, forgotten Relic Worlds to explore, and more archaeological treasures to unearth. Learn more with a feature breakdown trailer from our Game Director, Daniel Moregard here:

Annual General Meeting held

The Annual General Meeting (AGM) of Bonheur ASA was held today, Tuesday 28 May 2019. All items on the agenda, which had been sent to Oslo Stock Exchange on 7 May 2019, were resolved in accordance with the corresponding proposals placed before the AGM. The Chairman of the Shareholders’ Committee, Christian Fredrik Michelet chaired, the AGM. Also the Shareholder Committee members Jørgen G. Heje, Bård Mikkelsen, Einar Harboe and Ole Kristian Aabø-Evensen were present and so was the Chairman of the Board, Mr. Fred. Olsen and the proprietor of Fred. Olsen & Co., Anette S. Olsen. The AGM

Bulletin from annual general meeting in Sedana Medical AB (publ)

Sedana Medical AB (publ) (the "Company") held its annual general meeting on 28 May 2019 in Stockholm. The meeting resolved in accordance with all of the board of directors' and nomination committee's resolution proposals. Complete information on each resolution proposal that was approved by the meeting is available on www.sedanamedical.com. A summary of the resolutions that were made at the meeting is presented below.Adoption of the income statement and balance sheet and the consolidated income statement and consolidated balance sheet, as well as resolution on disposal of profits and

GomSpace: Early publication of quarterly results for the first quarter 2019

GomSpace Group AB (publ) (the ”Company”) has earlier communicated that the quarterly results for the first quarter 2019 will be published on May 31, 2019. Due to the fact that the work with the report has progressed faster than expected, the Company will publish the quarterly results for the first quarter 2019 on May 29, 2019. For more information, please contact:Niels Buus (CEO)Tel: +45 40 31 55 57E-mail: nbu @ gomspace.com About GomSpace Group ABThe company’s business operations are mainly conducted through the wholly-owned Danish subsidiary, GomSpace A/S, with operational

DDM Debt publishes bond prospectus and applies for listing of its bonds on Nasdaq Stockholm

DDM Debt AB (publ) (the "Company") has issued a senior secured bond loan of EUR 100,000,000 on 8 April 2019, within a total framework amount of EUR 150,000,000, on the Nordic bond market. The bonds carry a floating interest rate of EURIBOR plus 9.25 per cent. per annum and matures 8 April 2022. The Company will apply for listing of the bonds on the Corporate Bond list at Nasdaq Stockholm. The bonds will be admitted to trading at Nasdaq Stockholm as soon as possible. In connection with this, the Company has prepared a prospectus. The prospectus has been approved by, and registered with,

UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 28.05.2019

United Bankers Corporation NOTIFICATION 28.05.2019 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 28.05.2019 Date 28.05.2019Exchange transaction BuyShare class UNIAVAmount 152Average price/share 8.0000 EURHighest price/share 8.0000 EURLowest price/share 8.0000 EURTotal price 1,216.00 EUR The shares held by United Bankers Corporation on 28.05.2019: UNIAV 20,759 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ) Antti Salakka  Mikko

Extension of option for long-term charter with Aker Energy for the FPSO Dhirubhai-1

On the 12th of February 2019 Ocean Yield ASA (“Ocean Yield” or “the Company”) entered into an option agreement with Aker Energy AS (“Aker Energy”) for a long-term bareboat charter of the FPSO Dhirubhai-1. The option period expired on the 1st of May but was extended until the 30th of May 2019. Ocean Yield has today agreed with Aker Energy to further extend the option period until 1st September 2019 against an additional compensation. Aker Energy is currently evaluating different opportunities for the FPSO at the Deepwater Tano Cape Three Points (DWT/CTP) block offshore Ghana. As there is

Nordax issues SEK 500 million of senior unsecured bonds

Nordax Bank AB (publ) has issued SEK 500 million of senior unsecured bonds in the Nordic market. The 3 year bonds (with maturity June 2022) will be listed on Nasdaq Stockholm. The bonds are issued under Nordax Bank’s MTN programme with a total frame of SEK 3 billion and pays a coupon of 3m Stibor + 1.60%. Settlement date will be 7 June 2019 and maturity date 7 June 2022. Danske Bank acted as sole book runner in the transaction For further information, please contact: Andreas Frid, Head of Marketing & Communication, tel: +46 705 29 08 00 or andreas.frid@nordax.se  About Nordax

OssDsign AB (publ) further strengthens its patent portfolio

The European Patent Office (EPO) has issued that it intends to grant OssDsign AB two new European patents related to the company’s material technology and implant design. This further strengthens OssDsign’s extensive patent protection in the field of ceramic material formulations and their applications for medical use.The first patent covers the implant, its support structure, as well as the method of making a custom implant through additive manufacturing. The additive manufacturing process provides a number of advantages, including rapid fabrication of customized implants for each patient,

Correction: Trade subject to notification

On 11 April 2019, the Board of Directors of DNB ASA decided to offer employees in DNB ASA shares with a discount of 20 % (up to NOK 14,500 per employee). The shares were allotted today, 28 May 2019, at a gross price of NOK 153.2472 per share. Attached is a list of the primary insiders that availed themselves of the offer. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Navamedic ASA: Expands Imdur® distribution to Greece

Oslo, 9 May 2019 – Navamedic ASA (OSE: NAVA) today announced it is expanding distribution of the angina prevention medicine, Imdur®, to Greece, bringing the distribution to a total of 14 markets across Europe. “It is a pleasure to announce that Navamedic is expanding its distribution of Imdur to Greece from the end of April. Imdur is part of a strategic partnership with TopRidge Pharma Limited, under which the product has become Navamedic’s largest single brand. Although the generic competition has increased over the last years, the product is highly important for our customers and for

Single-family office invests 15 MEUR in Brighter through directed share issues.

The Board of Brighter AB has, with authorization from the Annual General Meeting on May 9, 2019, decided to carry out directed share issues totalling to EUR 15 million to Winance, a prominent single-family office (SFO) with offices in Dubai and New York. The capital will enable accelerated commercialization of Brighter’s flagship solution, Actiste® Diabetes Management as a Service, as well as further expansion and production. "We are embarked on an exciting journey from a pure development company to a growth company. Winance is a very successful investment company that has been

19-920 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#19-919 Delisting of certain derivative from NGM

Certain derivative will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Nordic Mining ASA – Contemplated Private Placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Nordic Mining ASA ("Nordic Mining" or the "Company") has retained Clarksons Platou Securities AS and Swedbank Norge, branch of Swedbank AB (publ) in cooperation with Kepler Cheuvreux as Joint Lead Managers and Bookrunners to advise on and effect a private placement directed

SRBANK – AT1 New issue

SpareBank 1 SR-Bank has issued NOK 250 million Perpetual NC5.5 AT1 with a coupon of 3 months nibor + 335. The Bank has bought back NOK 43.5 million of T1 bond NO0010552672 (ROGG56) at 3 months nibor + 50, remaining volume in the market is NOK 498.5 million. The Bank has also bought back NOK 5.5 million of T1 bond NO0010552664 (ROGG57) at 3 months nibor + 50, remaining volume in the market is NOK 64.5 million.  Contact at  SpareBank 1 SR-Bank: Dag A. Hjelle, tel. + 47 909 50 088

Metronidazol EQL Pharma approved

The pharmaceutical Metronidazol EQL Pharma, tablets 200mg and 400mg, has been approved by the Swedish Medicine Products Agency.Metronidazol EQL Pharma is a prescription drug used to treat infections caused by certain types of bacteria that live without oxygen (anaerobic bacteria). Metronidazol EQL Pharma is also used to treat infections caused by certain unicellular organisms (protozoa). Metronidazol EQL Pharma contains metronidazole, a substance that has been registered in Sweden since 1980. Metronidazol EQL Pharma becomes the first and only generic available in Sweden in the strengths

Fly non-stop from Gothenburg to Niš with Air Serbia

The carrier Air Serbia will start operations again at Göteborg Landvetter Airport after a break of seven years. Beginning July 17, travellers in western Sweden will be able to fly to the Serbian city of Niš. The direct route will be served by two weekly departures.  Air Serbia is once again returning to Göteborg Landvetter. The new destination is Niš, the third largest city in the country, located in eastern Serbia on the river Nišava. The city is situated in the heart of the Balkans and at the crossroads of European motorways connecting Asia and western Europe. “It is gratifying that

Navamedic ASA: Annual General Meeting held

Navamedic ASA has today, 28 May 2019, held an annual general meeting. All resolutions were made in accordance with the board's/nomination committee's proposals. The minutes from the general meeting is attached hereto and will be made available at www.navamedic.com. For further information please contact: Toril Ås, Chief Financial OfficerE-mail: toril.as@navamedic.comPhone +47 95 70 10 71 This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Neonode Announces Appointment of New Chief Financial Officer

STOCKHOLM, SWEDEN, May 28, 2019 — Neonode Inc. (NASDAQ: NEON), the optical sensing technology company, today announced the appointment of Maria Ek as new Chief Financial Officer (“CFO”), effective June 1, 2019. Lars Lindqvist, who has served as CFO of Neonode since August 2014 will remain available to assist with the transition of leadership responsibilities.Maria Ek has been serving as Corporate Controller for Neonode since December 2018. She previously held several financial management positions in international organizations including as Global Head of Accounting at Digital Route AB. “

poLight ASA: Minutes of Annual General Meeting

On May 28th 2019, the Annual General meeting was held in poLight ASA. All resolutions were adopted in accordance with the Board's proposal and the Nomination Committee's recommendation. poLight ASA - Minutes Ordinary General Meeting 2019  Further information from: Øyvind Isaksen, CEO, poLight ASA: +47 90 87 63 98 Alf Henning Bekkevik, CFO, poLight ASA: +47 91 63 05 14 About poLight ASA poLight has developed a new autofocus lens which "replicates" the human eye for use in mobile devices and other applications

Dometic presents financial targets at its Capital Markets Day

Stockholm, May 28, 2019 – Concluding today’s Capital Markets Day in Stockholm, Dometic (DOM-B.ST) presented the company’s financial targets over a business cycle.Juan Vargues, Dometic's CEO, and his management team presented the company’s financial targets over a business cycle aiming at an annual net sales growth of 10% (including acquisitions) and an EBIT-margin before items affecting comparability of 16-17%. The aim is that the Net Debt/EBITDA ratio should be around 2x. The dividend policy entails an ambition to pay back at least 40% of the annual net profit to the shareholders as

There are no items matching the current filter
There are no more items matching the current filter
Back to top